Avidity Biosciences Financial Overview
Avidity Biosciences's market cap is currently $10.91B. The company's EPS TTM is $-1.27; its P/E ratio is -17.31; Avidity Biosciences is scheduled to report earnings on November 10, 2025, and the estimated EPS forecast is $-1.24. See an overview of income statement, balance sheet, and cash flow financials.
